Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 191-196

  Han, Yiqun ^a   Zhang, Peng ^a   Chen, Yuanyuan ^a   Sun, Jiping ^a   Kong, Fansheng ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Active targeting; Co delivery; Gene therapy; Multifunctional delivery system

Indexed keywords

DOUBLE STRANDED DNA; DOXORUBICIN; ENHANCED GREEN FLUORESCENT PROTEIN; LIGAND; MACROGOL; PLASMID DNA; SOLID LIPID NANOPARTICLE; TRANSFERRIN; ANTINEOPLASTIC ANTIBIOTIC; GREEN FLUORESCENT PROTEIN; MACROGOL DERIVATIVE; NANOPARTICLE; PHOSPHATIDYLETHANOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG RELEASE; DRUG TARGETING; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CANCER CELL LINE; MOUSE; MTT ASSAY; MULTIFUNCTIONAL DELIVERY SYSTEM; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; DRUG SCREENING; GENE EXPRESSION; GENETICS; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; PLASMID; PROCEDURES; REPORTER GENE;

ADENOCARCINOMA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NANOPARTICLES; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; POLYETHYLENE GLYCOLS; TRANSFERRIN; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84902674049     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1770     Document Type: Article

References (36)

1. Shepherd FA, Bunn PA and Paz-Ares L: Lung cancer in 2013: state of the art therapy for metastatic disease. Am Soc Clin Oncol Educ Book: 339-346, 2013.
2. Sundaram S, Trivedi R, Durairaj C, Ramesh R, Ambati BK and Kompella UB: Targeted drug and gene delivery systems for lung cancer therapy. Clin Cancer Res 15: 7299-7308, 2009.
3. Siegel R, Ward E, Brawley O and Jamel A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
4. Kawabata A, Baoum A, Ohta N, Jacquez S, Seo GM, Berkland C and Tamura M: Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res 72: 2057-2067, 2012.
5. Bajelan E, Haeri A, Vali AM, Ostad SN and Dadashzadeh S: Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance. J Pharm Pharm Sci 15: 568-582, 2012.
6. Brannon-Peppas L and Blanchette JO: Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56: 1649-1659, 2004. (Pubitemid 39177694)
7. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002. (Pubitemid 37328807)
8. Liu C, Liu F, Feng L, Li M, Zhang J and Zhang N: The targeted co-delivery of DNA and doxorubicin to tumor cells via multi-functional PEI-PEG based nanoparticles. Biomaterials 34: 2547-2564, 2013.
9. Zheng C, Zheng M, Gong P, Deng J, Yi H, Zhang P, Zhang Y, Liu P, Ma Y and Cai L: Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Biomaterials 34: 3431-3438, 2013.
10. Loh XJ, Ong SJ, Tung YT and Choo HT: Co-delivery of drug and DNA from cationic dual-responsive micelles derived from poly(DMAEMA-co-PPGMA). Mater Sci Eng C Mater Biol Appl 33: 4545-4550, 2013.
11. Zhao J, Mi Y and Feng SS: Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles. Biomaterials 34: 3411-3421, 2013.
12. Shim G, Han SE, Yu YH, et al: Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug. J Control Release 155: 60-66, 2011.
13. Xu Z, Zhang Z, Chen Y, Chen L, Lin L and Li Y: The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model. Biomaterials 31: 916-922, 2010.
14. Qiu B, Ji M, Song X, et al: Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer. Nanoscale Res Lett 7: 666, 2012.
15. Kaneshiro TL and Lu ZR: Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials 30: 5660-5666, 2009.
16. Jiang Z, Sun C, Yin Z, Zhou F, Ge L, Liu X and Kong F: Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems. Int J Nanomedicine 7: 2019-2031, 2012.
17. Wang W, Zhou F, Ge L, Liu X and Kong F: Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomedicine 7: 2513-2522, 2012.
18. Kong F, Ge L, Liu X, Huang N and Zhou F: Mannan-modified PLGA nanoparticles for targeted gene delivery. Int J Photoenergy 2012: 926754, 2012.
19. Kong F, Zhou F, Ge L, Liu X and Wang Y: Mannosylated liposomes for targeted gene delivery. Int J Nanomedicine 7: 1079-1089, 2012.
20. Olbrich C, Bakowsky U, Lehr CM, Müller RH and Kneuer C: Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Control Release 77: 345-355, 2011.
21. Vighi E, Ruozi B, Montanari M, Battini R and Leo E: Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze - dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Eur J Pharm Biopharm 67: 320-328, 2007. (Pubitemid 47211893)
22. Bellocq NC, Pun SH, Jensen GS and Davis ME: Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 14: 1122-1132, 2003. (Pubitemid 37449039)
23. Li H and Qian ZM: Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 22: 225-250, 2002. (Pubitemid 34415465)
24. Maruyama K: Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 63: 161-169, 2011.
25. Torchilin VP: Multifunctional nanocarriers. Adv Drug Deliv Rev 58: 1532-1555, 2006.
26. Torchilin VP: Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4: 145-160, 2005.
27. Lukyanov AN, Gao Z, Mazzola L and Torchilin VP: Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice. Pharm Res 19: 1424-1429, 2002. (Pubitemid 35266545)
28. Miao J, Du YZ, Yuan H, Zhang XG and Hu FQ: Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids Surf B Biointerfaces 110: 74-80, 2013.
29. Gao X, Wang B, Wei X, et al: Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer. Int J Nanomedicine 8: 971-982, 2013.
30. Men K, Liu W, Li L, et al: Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system. Nanoscale 4: 6425-6433, 2012.
31. Wang BL, Gao X, Men K, et al: Treating acute cystitis with biodegradable micelle-encapsulated quercetin. Int J Nanomedicine 7: 2239-2247, 2012.
32. Li P, Liu D, Miao L, Liu C, Sun X, Liu Y and Zhang N: A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomedicine 7: 925-939, 2012.
33. 4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery. Int J Nanomedicine 7: 1697-1708, 2012.
34. He SN, Li YL, Yan JJ, Zhang W, Du YZ, Yu HY, Hu FQ and Yuan H: Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery. Int J Nanomedicine 8: 2859-2869, 2013.
35. Mehnert W and Mäder K: Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47: 165-196, 2001. (Pubitemid 32324113)
36. Singh M: Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr Pharm Des 5: 443-451, 1999.